Top Markets
#1 Naoris Protocol Naoris Protocol +19.86%
#2 pippin pippin +15.85%
#3 IQ IQ +14.14%
#4 peaq peaq +11.65%
#5 Bedrock Bedrock +11.38%
#6 Ridges AI Ridges AI +9.13%
#7 Chrema Coin Chrema Coin +7.92%
#8 FLOCK FLOCK +7.88%
#9 Bittensor Bittensor +7.58%
#10 affine affine +7.57%
Coin of the day
Naoris Protocol Naoris Protocol
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Medtronic plc Medtronic plc

Medtronic plc

2M6
Peringkat dalam Saham #166
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Harga Saham
$88.76
Kapitalisasi Pasar
$113.96B
Perubahan (1 hari)
-0.15%
Perubahan (1 tahun)
-1.87%
Negara
IE
Perdagangan Medtronic plc (2M6)

Kategori

Healthcare
Rasio P/E untuk Medtronic plc (2M6)
Rasio P/E per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Medtronic plc, rasio P/E saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki rasio P/E sebesar 0.
Riwayat rasio P/E untuk Medtronic plc dari 2026 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 28.93 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 39.68 -
US
Medtronic Medtronic
Medtronic
MDT.US
 24.21 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 35.47 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SMMNY.US
 20.43 -
DE
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.